Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
During persistent viral infections, chronic immune activation, negative immune regulator expression, an elevated interferon signature, and lymphoid tissue destruction correlate with disease progression. We demonstrated that blockade of type I interferon (IFN-I) signaling using an IFN-I receptor neutralizing antibody reduced immune system activation, decreased expression of negative immune regulatory molecules, and restored lymphoid architecture in mice persistently infected with lymphocytic choriomeningitis virus. IFN-I blockade before and after establishment of persistent virus infection resulted in enhanced virus clearance and was CD4 T cell-dependent. Hence, we demonstrate a direct causal link between IFN-I signaling, immune activation, negative immune regulator expression, lymphoid tissue disorganization, and virus persistence. Our results suggest that therapies targeting IFN-I may help control persistent virus infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, during viral infections, chronic type I and II IFN signaling can lead to immune suppression and a failure to clear viral infection.51-53”
From Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma (2021) · cites this paper as [51]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2006) · Nature · doi:10.1038/nature04444 · Cited by 3,986
Mechanisms of type-I- and type-II-interferon-mediated signalling
Platanias, L. C. (2005) · Nature Reviews Immunology · doi:10.1038/nri1604 · Cited by 3,491
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
A diverse range of gene products are effectors of the type I interferon antiviral response
Schoggins, J. W., Wilson, S. J., Panis, M., Murphy, M. Y., Jones, C. T., Bieniasz, P., & Rice, C. M. (2011) · Nature · doi:10.1038/nature09907 · Cited by 2,433
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
Interferon-stimulated genes and their antiviral effector functions
Schoggins, J. W., & Rice, C. M. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.10.008 · Cited by 1,289
Type I Interferons in Host Defense
Stetson, D. B., & Medzhitov, R. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.007 · Cited by 1,195
Genomic analysis of the host response to hepatitis C virus infection
Su, A. I., Pezacki, J. P., Wodicka, L., Brideau, A. D., Supekova, L., Thimme, R., Wieland, S., Bukh, J., Purcell, R. H., Schultz, P. G., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202608199 · Cited by 1,161
Interleukin-10 determines viral clearance or persistence in vivo
Brooks, D. G., Trifilo, M. J., Edelmann, K. H., Teyton, L., McGavern, D. B., & Oldstone, M. B. A. (2006) · Nature Medicine · doi:10.1038/nm1492 · Cited by 923
Self-citationIMMUNOBIOLOGY AND PATHOGENESIS OF VIRAL HEPATITIS
Guidotti, L. G., & Chisari, F. V. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100230 · Cited by 811
Cited by
Items 401–500 of 759
Honke, N., Shaabani, N., Merches, K., Gassa, A., Kraft, A. R. M., Ehrhardt, K., Häussinger, D., Löhning, M., Dittmer, U., Hengel, H., et al. (2015) · European Journal of Immunology · doi:10.1002/eji.201545765 · Cited by 25
Khattar, R., Luft, O., Nataliya, Y., Shalev, I., Phillips, M. J., Adeyi, O. A., Gao, D. F., Bartczak, A. M., Urbanellis, P., Shyu, W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072309 · Cited by 25
“[29] who showed that the expression of type I interferon reflects the level of viral replication, as well as the interplay between immune activation and suppression by negative regulators.”
BackgroundPrice, A. A., Tedesco, D., Prasad, M. R., Workowski, K., Walker, C. M., Suthar, M. S., Honegger, J. R., & Grakoui, A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602319113 · Cited by 25
“” Indeed, in a mouse model of chronic infection, blockade of type I IFN before infection with lymphocytic choriomeningitis virus clone 13 enhanced viral load during the acute phase of infection, but led to viral clearance at later time points (23, 24).”
BackgroundTuberculosis as an unconventional interferonopathy
Vance, R. E. (2024) · Current Opinion in Immunology · doi:10.1016/j.coi.2024.102508 · Cited by 24
Lin, X., Li, X., Zhai, Z., & Zhang, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1563286 · Cited by 29
Distinct Molecular Mechanisms of Host Immune Response Modulation by Arenavirus NP and Z Proteins
Stott-Marshall, R. J., Strecker, T., & Foster, T. L. (2020) · Viruses · doi:10.3390/v12070784 · Cited by 28
Quezada, L. K., Jin, W., Liu, Y. C., Kim, E. S., He, Z., Indralingam, C. S., Tysl, T., Labarta-Bajo, L., Wehrens, E. J., Jo, Y., et al. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3001983 · Cited by 27
The Complexity of Interferon Signaling in Host Defense against Protozoan Parasite Infection
Deng, S., Graham, M. L., & Chen, X. (2023) · Pathogens · doi:10.3390/pathogens12020319 · Cited by 25
Sustained IFN signaling is associated with delayed development of SARS-CoV-2-specific immunity
Brunet‐Ratnasingham, E., Morin, S., Randolph, H. E., Labrecque, M., Bélair, J., Lima-Barbosa, R., Pagliuzza, A., Marchitto, L., Hultström, M., Niessl, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48556-y · Cited by 28
“Seminal studies in the murine lymphocytic chor-iomeningitis virus (LCMV) model support this hypothesis 28,39 : while IFNsarecriticalintheearlygenerationofantiviralresponses,sustained type I IFN signaling in chronic Clone 13 infection was associated with poor antibody, B cell and CD4 + T cell…”
Interaction between unrelated viruses during in vivo co-infection to limit pathology and immunity
McAfee, M. S., Huynh, T. P., Johnson, J. L., Jacobs, B. L., & Blattman, J. N. (2015) · Virology · doi:10.1016/j.virol.2015.05.021 · Cited by 25
“Because LCMV is known to induce potent Type I Interferon responses(42), and ECTV is sensitive to Type I Interferons(37, 56), we next hypothesized that the early innate immune suppression of ECTV could be due to an overwhelming IFN-I response.”
BackgroundIL-27 Suppresses Antimicrobial Activity in Human Leprosy
Teles, R. M. B., Kelly‐Scumpia, K. M., Sarno, E. N., Rea, T. H., Ochoa, M. T., Cheng, G., & Modlin, R. L. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.195 · Cited by 28
“, 2013) and viral (Teijaro et al., 2013; Wilson et al., 2013) infections.”
BackgroundMoore, T. C., Cody, L. A., Kumm, P. M., Brown, D. M., & Petro, T. M. (2013) · Virus Research · doi:10.1016/j.virusres.2013.10.003 · Cited by 25
“These results suggest that the antiviral effects of both IL-6 and IFN-γ require IRF3 downstream of their receptors and are consistent with recent reports showing that IFNγ expression exacerbates chronic viral infections when given later during infection (Teijaro et al., 2013; Wilson et al., 2013).”
ResultTLR4 signaling improves PD-1 blockade therapy during chronic viral infection
Wang, Y., Chung, Y. R., Eitzinger, S., Palacio, N. M., Gregory, S., Bhattacharyya, M., & Penaloza‐MacMaster, P. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007583 · Cited by 25
Zivcec, M., Spiropoulou, C. F., & Spengler, J. R. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2019.104702 · Cited by 24
Riedelberger, M., Penninger, P., Tscherner, M., Hadriga, B., Brunnhofer, C., Jenull, S., Stoiber, A., Bourgeois, C., Petryshyn, A., Glaser, W., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101121 · Cited by 23
Epidemiologic, Clinical and Immunological Consequences of Co-Infections during Canine Leishmaniosis
Beasley, E. A., Pessôa-Pereira, D., Scorza, B. M., & Petersen, C. A. (2021) · Animals · doi:10.3390/ani11113206 · Cited by 26
Shiiya, A., Noguchi, T., Tomaru, U., Ariga, S., Takashima, Y., Ohhara, Y., Taguchi, J., Takeuchi, S., Shimizu, Y., Kinoshita, I., et al. (2022) · Cancer Science · doi:10.1111/cas.15701 · Cited by 24
Bhattacharyya, M., Madden, P. J., Henning, N. F. C., Gregory, S., Aïd, M., Martinot, A. J., Barouch, D. H., & Penaloza‐MacMaster, P. (2017) · Immunology · doi:10.1111/imm.12771 · Cited by 23
Crisler, W. J., & Lenz, L. L. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.05.014 · Cited by 25
“Mice pre-treated with blocking antibodies against IFNAR exhibit decreased expression of immune-suppressive PD-L1 and an increased clearance of LCMV that relies on IFNγ responsiveness [27, 28].”
BackgroundCognitive Consequences of a Sustained Monocyte Type 1 IFN Response in HIV-1 Infection
Pulliam, L. (2014) · Current HIV Research · doi:10.2174/1570162x12666140526113544 · Cited by 22
“A mouse model of persistent LCMV infection is accompanied by chronic type 1 IFN signaling, hyperactivation and disease progression [71, 72].”
BackgroundResultWijesundara, D. K., Xi, Y., & Ranasinghe, C. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00412 · Cited by 23
Childs, K., Merritt, E., Considine, A., Fueyo, A. S., Agarwal, K., Martínez‐Llordella, M., & Carey, I. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx067 · Cited by 22
“The innate immune response contributes to the inadequacy of the adaptive response, because abrogation of IFN signaling in animal models reduces T-cell exhaustion [13].”
BackgroundGoropevšek, A., Gorenjak, M., Gradišnik, S., Dai, K., Holc, I., Hojs, R., Krajnc, I., Pahor, A., & Avčin, T. (2017) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2016.0040 · Cited by 22
The pros and cons of dying tumour cells in adaptive immune responses
Wang, X., Lu, X., & Sun, B. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.87 · Cited by 26
Baral, S., Roy, R., & Dixit, N. M. (2018) · Immunology and Cell Biology · doi:10.1111/imcb.12161 · Cited by 22
“Furthermore, blockade of interferon signaling during chronic LCMV infection of mice has been shown recently to clear the infection.(49,50) Whether a critical time following infection exists within which the start of PR therapy does not exacerbate CTL exhaustion remains to be ascertained.”
BackgroundHIV-1 Infection and Type 1 Interferon: Navigating Through Uncertain Waters
Sugawara, S. K., Thomas, D. L., & Balagopal, A. (2018) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2018.0161 · Cited by 22
The ubiquitin-like modifier FAT10 is required for normal IFN-γ production by activated CD8+ T cells
Mah, M. M., Basler, M., & Groettrup, M. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.02.010 · Cited by 22
Pathogenic Role of Type I Interferons in HIV-Induced Immune Impairments in Humanized Mice
Su, L. (2019) · Current HIV/AIDS Reports · doi:10.1007/s11904-019-00444-7 · Cited by 22
Type I interferon regulation of natural killer cell function in primary and secondary infections
Stackaruk, M. L., Lee, A. J., & Ashkar, A. A. (2013) · Expert Review of Vaccines · doi:10.1586/14760584.2013.814871 · Cited by 23
Self-citationMeasles virus induces persistent infection by autoregulation of viral replication
Doi, T., Kwon, H.-J., Honda, T., Sato, H., Yoneda, M., & Kai, C. (2016) · Scientific Reports · doi:10.1038/srep37163 · Cited by 22
Interferon regulatory factor 2 protects mice from lethal viral neuroinvasion
Li, M. M. H., Bozzacco, L., Hoffmann, H.-H., Breton, G., Loschko, J., Xiao, J., Monette, S., Rice, C. M., & MacDonald, M. R. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20160303 · Cited by 25
“Neutralization of type I IFN signaling during persistent lymphocytic choriomeningitis virus (LCMV) infection reduces immune system activation, restores lymphoid architecture, and allows for viral clearance (Teijaro et al., 2013; Wilson et al., 2013).”
BackgroundMaarifi, G., Martin, M. F., Zebboudj, A., Boulay, A., Nouaux, P., Fernandez, J., Lagisquet, J., Garcin, D., Gaudin, R., Arhel, N. J., et al. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2022.05.009 · Cited by 22
“Alternatively, the AlphaCen system can also be adapted to screen for inhibitors of innate immunity that can be applicable to chronic infections, as demonstrated by the treatment of chronic lymphocytic choriomeningitis virus (LCMV) in mice (Teijaro et al., 2013) and auto-immune diseases.”
Durand, A., Bonilla, N., Level, T., Ginestet, Z., Lombès, A., Guichard, V., Germain, M., Jacques, S., Letourneur, F., Cruzeiro, M. D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45984-8 · Cited by 21
“First, type 1 interferon blockade after establishment of chronic LCMV infection leads to enhanced CD4 T-cell and IFN-γ -dependent clearance of the virus 83,84 .”
BackgroundActivation of endogenous type I IFN signaling contributes to persistent HCV infection
Li, Y., Li, S., Duan, X., Liu, B., Yang, C., Zeng, P., McGilvray, I. D., & Chen, L. (2014) · Reviews in Medical Virology · doi:10.1002/rmv.1795 · Cited by 22
“Most recently, two independent studies [19,20] reported that blockade of type I IFN signaling may help to cure persistent infection of LCMV clone 13 (LCMV-Cl13) in vivo.”
BackgroundIFN-β: A Contentious Player in Host–Pathogen Interaction in Tuberculosis
Sabir, N., Hussain, T. A., Shah, S. Z. A., Zhao, D., & Zhou, X. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122725 · Cited by 24
Fc gamma receptor IIa suppresses type I and III interferon production by human myeloid immune cells
Newling, M., Hoepel, W., Vogelpoel, L. T. C., Heineke, M. H., van Burgsteden, J. A., Taanman-Kueter, E. W., Eggink, D., Kuijpers, T. W., Beaumont, T., van Egmond, M., et al. (2018) · European Journal of Immunology · doi:10.1002/eji.201847615 · Cited by 21
Enhancement of Antitumor Vaccination by Targeting Dendritic Cell-Related IL-10
Llópiz, D., Ruiz, M., Silva, L., & Sarobe, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01923 · Cited by 25
“IL-10 and type I IFN production have been linked as regulatory mechanisms, and blockade of IFN signal leads to a diminished IL-10 expression (81, 82).”
BackgroundResultIshihara, R., Watanabe, R., Shiomi, M., Fujita, Y., Katsushima, M., Fukumoto, K., Yamada, S., & Hashimoto, M. (2025) · Biomolecules · doi:10.3390/biom15111586 · Cited by 24
“Conversely, during persistent IFN-I signatures, myeloid differentiation and DC proliferation are suppressed, yielding an inhibitory phenotype characterized by reduced splenic CD11c + cells and elevated PD-L1 and IL-10 expression [154–156].”
InfluentialThe added value of type I interferons to cytotoxic treatments of cancer
Bracci, L., Sistigu, A., Proietti, E., & Moschella, F. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.06.008 · Cited by 21
IFNα Subtypes in HIV Infection and Immunity
Karakoese, Z., Ingola, M., Sitek, B., Dittmer, U., & Sutter, K. (2024) · Viruses · doi:10.3390/v16030364 · Cited by 20
“Similar observations were also reported from chronic infections with Lymphocytic Choriomeningitis Virus (LCMV) in mice, in which blockade of IFNAR1 resulted in the control of persistent LCMV infection [88,89].”
ResultGreene, T. T., Jo, Y., Chiale, C., Macal, M., Fang, Z., Khatri, F. S., Codrington, A. L., Kazane, K. R., Akbulut, E., Swaminathan, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56603-5 · Cited by 22
Pulliam, L., Calosing, C., Sun, B., Grünfeld, C., & Rempel, H. C. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2013.0152 · Cited by 23
Scala, M. D., Otano, I., Gil-Fariña, I., Vanrell, L., Hommel, M., Olagüe, C., Vales, Á., Galarraga, M., Guembe, L., Ortíz-de-Solórzano, C., et al. (2016) · Journal of Virology · doi:10.1128/jvi.01030-16 · Cited by 20
Olferiev, M., Jacek, E., Kirou, K. A., & Crow, M. K. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.08.018 · Cited by 20
HIV-antibody complexes enhance production of type I interferon by plasmacytoid dendritic cells
Veenhuis, R. T., Freeman, Z. T., Korleski, J., Cohen, L. K., Massaccesi, G., Tomasi, A. G., Boesch, A. W., Ackerman, M. E., Margolick, J. B., Blankson, J. N., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci95375 · Cited by 20
Fu, B., Wang, D., Shen, X., Guo, C., Liu, Y., Ye, Y., Sun, R., Li, J., Tian, Z., & Wei, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.591269 · Cited by 21
“IFNa has been reported to lead to the production of immunosuppressive molecules in models of Simian Immunodeficiency Virus (SIV) (39) and LCMV infection (11, 12).”
BackgroundInflammasome Activation Dampens Type I IFN Signaling to Strengthen Anti- Toxoplasma Immunity
Hu, Z., Wu, D., Lu, J., Zhang, Y., Yu, S.-M., Xie, Y., Li, H., Yang, J., Lai, D., Zeng, K., et al. (2022) · mBio · doi:10.1128/mbio.02361-22 · Cited by 22
Hoffman, K. W., Sachs, D. M., Bardina, S. V., Michlmayr, D., Rodriguez, C. A., Sum, J., Foster, G. A., Krysztof, D. E., Stramer, S. L., & Lim, J. K. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw179 · Cited by 20
“much initial inflammation may negatively impact how these adaptive T-cell responses are shaped, as appears to be the case for WNV infection in our cohort [23, 24].”
BackgroundTumor-necrosis factor is a master of T cell exhaustion
Baxter, A. E., & Kaufmann, D. (2016) · Nature Immunology · doi:10.1038/ni.3436 · Cited by 20
Slow viral propagation during initial phase of infection leads to viral persistence in mice
Xu, H. C., Wang, R., Shinde, P. V., Walotka, L., Huang, A., Poschmann, G., Huang, J., Liu, W. Y., Stühler, K., Schaal, H., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02028-x · Cited by 20
Exposing the Two Contrasting Faces of STAT2 in Inflammation
Duodu, P., Sosa, G., Canar, J., Chhugani, O., & Gamero, A. M. (2022) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2022.0117 · Cited by 20
Bénard, A., Hansen, F. J., Uhle, F., Klösch, B., Czubayko, F., Mittelstädt, A., Jacobsen, A., David, P., Podolska, M. J., Anthuber, A., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1140630 · Cited by 22
“Whereas type I interferons are critical for early immune responses against acute lymphocytic choriomeningitis virus (LCMV) infections, they contribute to the altered immunity during chronic LCMV infections (41, 42).”
BackgroundIL-27 expression regulation and its effects on adaptive immunity against viruses
Andres-Martin, F., James, C., & Catálfamo, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1395921 · Cited by 19
“The rapid upregulation of IL-27 expression (IL-27p28) occurs with the early induction of Type I IFNs (91, 92).”
BackgroundCalvo, T. R., Rojas, J. M., Martín, V., & Sevilla, N. (2013) · Journal of Virology · doi:10.1128/jvi.02697-13 · Cited by 19
“IFN-I plays an important role in systemic viral infections (31, 36),”
BackgroundKadmon, C. S., Landers, C. T., Li, H. S., Watowich, S. S., Rodríguez, A., & King, K. Y. (2017) · Experimental Hematology · doi:10.1016/j.exphem.2017.09.001 · Cited by 20
Manipulating the Interferon Signaling Pathway: Implications for HIV Infection
Nganou‐Makamdop, K., & Douek, D. C. (2019) · Virologica Sinica · doi:10.1007/s12250-019-00085-5 · Cited by 20
Gan, C., Li, W. F., Li, C. N., Li, L. L., Zhou, W., & Peng, X.-M. (2020) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2020.100763 · Cited by 19
Riding, R. L., Richmond, J. M., Fukuda, K., & Harris, J. E. (2020) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12935 · Cited by 21
“Type I IFNs can contribute to impaired host adaptive immune responses during chronic infections (Cheng et al., 2017; Teijaro et al., 2013).”
BackgroundRoles of IκB kinase ε in the innate immune defense and beyond
Zhang, J., Tian, M., Xia, Z., & Feng, P. (2016) · Virologica Sinica · doi:10.1007/s12250-016-3898-y · Cited by 20
“The dramatically reduced γHV68 latent infection in IKKε-deficient mice is reminiscent of the observation that blockade of type I IFNs reduced LCMV latent infection in mice (Teijaro et al., 2013; Wilson et al., 2013) .”
BackgroundCitro, A., Scrivo, R., Martini, H., Martire, C., Marzio, P. D., Vestri, A. R., Sidney, J., Sette, A., Barnaba, V., & Valesini, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128607 · Cited by 19
“Recently, a strict relationship between sustained type I IFN (IFN-I) signaling and PD-1 overexpression on T cells, resulting in the establishment of a low level of CIA and decreased effector functions by virus-specific T cells, has been demonstrated in the mouse model of persistent lymphocytic choriomeningitis virus i…”
BackgroundRichmond, O. B., Cecere, T. E., Erdogan, E., Meng, X., Piñeyro, P. E., Subramaniam, S., Todd, S. M., & LeRoith, T. (2015) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2015.09.013 · Cited by 19
“…may contribute o the mechanism(s) of lymphocytic loss, particularly T-cells, in ases of PCVAD. d Immunopathology 168 (2015) 24–29 The increase of PD-L1 expression induced by IFNs- and is in agreement with previous research done in other animal models (Muhlbauer et al., 2006; Teijaro et al., 2013).”
ResultExpression of Id3 represses exhaustion of anti-tumor CD8 T cells in liver cancer
Jin, Y., Hu, P., Sun, H., Yang, C., Zhai, J., Wang, Y., Chu, X., Sun, Z., Wang, J., Sun, J., et al. (2022) · Molecular Immunology · doi:10.1016/j.molimm.2022.02.005 · Cited by 19
Heterogeneity and functions of the 13 IFN‐α subtypes – lucky for some?
Moreau, T., Bondet, V., Rodero, M. P., & Duffy, D. (2023) · European Journal of Immunology · doi:10.1002/eji.202250307 · Cited by 19
Choi, S.-H., Lee, J., Kim, S., Lee, Y. W., Kim, G.-C., Hong, S.-M., An, S.-H., Noh, H., Kim, K. E., On, D., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2023.104932 · Cited by 19
The PD-1/PD-L1 pathway and Epstein–Barr virus
Wang, H., Zhang, N., Xu, R., Ji, C., Wei, Y., Liu, Z., & Mi, Q. S. (2025) · European journal of medical research · doi:10.1186/s40001-025-02694-1 · Cited by 20
“Studies have shown that suppression or deficiency of the type I IFN signaling pathway leads to reduced PD-L1 expression during chronic LCMV infection, despite increased viral replication [89, 90].”
Two separate mechanisms of enforced viral replication balance innate and adaptive immune activation
Shaabani, N., Khairnar, V., Duhan, V., Zhou, F., Ferrer-Tur, R., Häussinger, D., Recher, M., Tumanov, A. V., Hardt, C., Pinschewer, D. D., et al. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.10.004 · Cited by 19
Co‐inhibitory blockade while preserving tolerance: checkpoint inhibitors for glioblastoma
Lucca, L. E., & Hafler, D. A. (2017) · Immunological Reviews · doi:10.1111/imr.12529 · Cited by 18
Gill, U. S., & Kennedy, P. T. F. (2018) · Journal of Viral Hepatitis · doi:10.1111/jvh.13040 · Cited by 21
Immune Profiling of COVID-19 in Correlation with SARS and MERS
Khalil, B. A., Shakartalla, S. B., Goel, S., Mdkhana, B., Halwani, R., Maghazachi, A. A., AlSafar, H. S., Al‐Omari, B., & Bataineh, M. T. A. (2022) · Viruses · doi:10.3390/v14010164 · Cited by 19
SARS‐CoV‐2, HIV, and HPV: Convergent evolution of selective regulation of cGAS–STING signaling
Shen, S., Rui, Y., Wang, Y., Su, J., & Yu, X. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28220 · Cited by 18
Inflammatory platelet production stimulated by tyrosyl-tRNA synthetase mimicking viral infection
Morodomi, Y., Kanaji, S., Sullivan, B. M., Zarpellon, A., Orje, J. N., Won, E., Shapiro, R., Yang, X., Ruf, W., SCHIMMEL, P. R., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2212659119 · Cited by 27
Self-citationWang, T., Chen, Y., Wang, Y., Lee, S., Lee, Y., & Dong, J. (2024) · Advanced Sensor Research · doi:10.1002/adsr.202400142 · Cited by 19
Nef, the shuttling molecular adaptor of HIV, influences the cytokine network
Percario, Z. A., Ali, M., Mangino, G., & Affabris, E. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.11.010 · Cited by 20
“Curiously, blockade of type I IFN signaling helps resolve persistent infection by LCMV in a mouse model [166,167] suggesting that impeding interferon signaling in”
BackgroundMoyano, A. L., Steplowski, J., Wang, H., Son, K., Rapolti, D. I., Marshall, J. N., Elackattu, V., Marshall, M. S., Hebert, A., Reiter, C. R., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.01.008 · Cited by 17
Cytokine Storm May Not Be the Chief Culprit for the Deterioration of COVID-19
Gao, Y., Wang, C., Kang, K., Peng, Y., Luo, Y., Liu, H., Yang, W. Z., Zhao, M., & Yu, K. (2020) · Viral Immunology · doi:10.1089/vim.2020.0243 · Cited by 17
“Furthermore, IFN impaired T cell responses by upregulating the expression of negative immunoregulatory molecules, for example programmed cell death-1 (PD-1) and Lymphocyte activation gene-3 (LAG-3) (29).”
Mechanisms of Immune Modulation by Radiation
Spina, C. S., & Drake, C. G. (2021) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2021.02.001 · Cited by 18
Xu, L., Fan, X., Zhao, Q.-Z., Zhang, Z.-X., Chen, K., Yi-bao, N., Zhang, Q.-Y., Zou, X., Zhu, Y., Cui, L., et al. (2017) · Viral Immunology · doi:10.1089/vim.2017.0010 · Cited by 17
“IFN-I signals possess antiviral and immune stimulatory potential required for the clearance of infection, but when virus cannot be controlled, these sustained IFN-I signals induce overexpression of inflammatory cytokines and chemokines, which may do harm to immune cells and immune organs, and lead to immunosuppression…”
The Janus Face of Follicular T Helper Cells in Chronic Viral Infections
Greczmiel, U., & Oxenius, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01162 · Cited by 19
Bailey, A. L., Buechler, C. R., Matson, D. R., Peterson, E. J., Brunner, K. G., Mohns, M. S., Breitbach, M. E., Stewart, L. M., Ericsen, A. J., Newman, C. M., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006692 · Cited by 17
BST2 expression at astrocyte borders promotes microglial recruitment via the C3/C3aR signaling
Zhang, S., Yuan, M., Zhou, J., Yuan, Z. K., Wang, L., Gong, C., Lu, H., Cheng, X., Wang, X., He, Q., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.09.038 · Cited by 17
Tian, W., Qin, G., Jia, M., Li, W., Cai, W., Wang, H., Zhao, Y., Bao, X., Wei, W., Zhang, Y., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1198551 · Cited by 19
Bullock, C. B., Wang, L., Ware, B. C., Wagoner, N., Ohara, R. A., Liu, T., Desai, P., Peters, B., MURPHY, K. M. M., Handley, S. A., et al. (2024) · mBio · doi:10.1128/mbio.02930-24 · Cited by 17
“Alternatively, anti-IFNAR1 mAb treatment may help correct a functionally overactive innate immune response, such as that occurring during the chronic stage of LCMV clone 13 infection, where the IFNAR1 blockade improved CD8 + T-cell viral control (53, 54).”
Direct-Acting Antivirals Cure Innate Immunity in Chronic Hepatitis C
Mondelli, M. U. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.026 · Cited by 16
Antiviral Effect of Interferon Lambda Against Lymphocytic Choriomeningitis Virus
Lukáčiková, Ľ., Ovečková, I., Betáková, T., Laposova, K., Polčicová, K., Pastoreková, S., Pastorek, J., & Tomášková, J. (2015) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0083 · Cited by 16
Negrotto, S., Mena, H. A., Ure, A. E., de Giusti, C. J., Bollati‐Fogolín, M., Vermeulen, E. M., Schattner, M. A., & Gomez, R. M. (2015) · Journal of Virology · doi:10.1128/jvi.01014-15 · Cited by 16
“In mice intravenously infected with a high dose (2 3 10(6) PFU) of LCMV, virus persistence is controlled by blocking IFN-I signaling (37, 38).”
BackgroundJiang, R., Han, B., Song, M., Xue, B., Zhang, Y., Ding, Y., Jin, C., Zhu, J., Liu, J., Nie, Q., et al. (2020) · Journal of Inflammation · doi:10.1186/s12950-020-00249-1 · Cited by 16
IFNAR1 signaling in NK cells promotes persistent virus infection
Huang, Z., Kang, S. G., Li, Y., Žák, J., Shaabani, N., Deng, K., Shepherd, J., Bhargava, R., Teijaro, J. R., & Xiao, C. (2021) · Science Advances · doi:10.1126/sciadv.abb8087 · Cited by 17
Self-citationJohnson, E. L., Swieboda, D., Olivier, A., Enninga, E. A. L., & Chakraborty, R. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009860 · Cited by 18
“Type I IFN, through the IFN-α/β receptor (IFNAR), induce a multitude of IFN-stimulated genes (ISGs) that can block viral replication and alert the immune system in response to virus [33, 42, 43].”
BackgroundSrivastava, S., Koch, L. K., & Campbell, D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401039 · Cited by 17
Too Much of a Good Thing? Chronic IFN Fuels Resistance to Cancer Immunotherapy
Reading, J. L., & Quezada, S. A. (2016) · Immunity · doi:10.1016/j.immuni.2016.12.004 · Cited by 16
“Emerging evidence of the immunoregulatory effects of IFN signaling presented here and elsewhere (Teijaro et al., 2013; Wilson et al., 2013) sheds light on these findings.”
BackgroundStudstill, C. J., & Hahm, B. (2021) · Viruses · doi:10.3390/v13101951 · Cited by 16
Li, H., Evans, T. I., Gillis, J. M., Connole, M., & Reeves, R. K. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu671 · Cited by 15
“persistent viral infections, such as HIV and SIV infection [13, 20–23] and lymphocytic choriomeningitis virus (LCMV) infection [24], and in autoimmune diseases [25–27].”
BackgroundTarbell, K. V., & Egen, J. G. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mir1017-400r · Cited by 16
Kawashima, K., Isogawa, M., Hamada‐Tsutsumi, S., Baudi, I., Saito, S., Nakajima, A., & Tanaka, Y. (2018) · Journal of Virology · doi:10.1128/jvi.01099-18 · Cited by 15
“lymphocytic choriomeningitis virus (LCMV) (35, 36).”
ResultRaju, S., Verbaro, D., & Egawa, T. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.092 · Cited by 15
Serum levels of type I interferon (IFN-I) is associated with the severity of COVID-19
Sun, Y., Wang, G., Wang, R., Ren, L., Yuan, Z., Liu, Y., Wu, Y., Chen, R., Chen, Y., & Diao, B. (2023) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001694 · Cited by 15
IFN-β Selectively Inhibits IL-2 Production through CREM-Mediated Chromatin Remodeling
Otero, D. C., Fares-Frederickson, N. J., Xiao, M., Baker, D. P., & David, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403181 · Cited by 15
Manske, K., Kallin, N., König, V., Schneider, A., Kurz, S., Bosch, M., Welz, M., Cheng, R., Bengsch, B., Steiger, K., et al. (2018) · Hepatology · doi:10.1002/hep.30080 · Cited by 16
Oldstone, M. B. A. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu501 · Cited by 16
“Finally, we are evaluating different strategies used by LCMV Cl 13 compared to LCMVArmstrong (ARM) for signaling the IFN-1α,β receptor (Figure 1).”
BackgroundMethodInfluentialSelf-citationSystemic Factors Mediate Reversible Age-Associated Brain Dysfunction
Mendelsohn, A. R., & Larrick, J. W. (2014) · Rejuvenation Research · doi:10.1089/rej.2014.1643 · Cited by 16
Metadata
- Authors
- Teijaro, J. R., Ng, C., Lee, A. M., Sullivan, B. M., Sheehan, K. C. F., Welch, M., Schreiber, R. D., Carlos de la Torre, J., & Oldstone, M. B. A.
- Affiliations
- Scripps Research Institute (US)
- Washington University in St. Louis (US)
- Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA.
- Corresponding author
- Teijaro, John R.
- Ng, Cherie
- Oldstone, Michael B. A.
- ORCID
- Venue
- Science
- Published
- 2013-04-12
- Volume
- 340
- Issue
- 6129
- Pages
- 207-211
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3640797
- OpenAlex
- W2024556668
- Cited by
- 755
- References
- 38
- Citations by year
- 2026: 32 · 2025: 40 · 2024: 39 · 2023: 40 · 2022: 42 · 2021: 49 · 2020: 56 · 2019: 55 · 2018: 55 · 2017: 73 · 2016: 86 · 2015: 80 · 2014: 71 · 2013: 37
- FWCI
- 50.55
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5t32ns041219-10, 5t32ai007354-30)
- National Heart, Lung, and Blood Institute (HL007195, T32HL007195)
- National Cancer Institute (R01CA043059, CA-43059, R37CA043059)
- National Institute of Allergy and Infectious Diseases (AI-077719, AI09484, AI-047140, R01AI009484, AI007354, R01AI047140, T32-AI007354., R56AI077719, R01AI077719, U54AI057160)
- National Institute of Neurological Disorders and Stroke (T32-NS041219, NS-041219)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Keywords
- lymphocytic choriomeningitis virus, viral persistence, type I interferon signaling, immune activation, negative immune regulation, CD4+ T cells, viral clearance, antiviral therapy
- MeSH terms
- Animals, Antibodies, Viral, Arenaviridae Infections, Dendritic Cells, Female, Immune Tolerance, Interferon Type I, Lymphocytes, Lymphocytic choriomeningitis virus, Male, Mice, Inbred C57BL, Spleen, Viremia, Signal Transduction, CD4-Positive T-Lymphocytes, Cytokines, Interleukin-10, Mice, Receptor, Interferon alpha-beta, B7-H1 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.